Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAVEX LIFE SCIENCES CORP. Director's Dealing 2020

Jan 9, 2020

32464_dirs_2020-01-08_b019c636-c2e5-42c4-b8fd-8e98318164d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2020-01-06

Reporting Person: Skarpelos Athanasios (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-06 Stock Option (Right to Buy) $2.96 A 50000 Acquired 2030-01-06 Common Stock (50000) Direct